UBS’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$341K Buy
40,400
+38,100
+1,657% +$361K ﹤0.01% 4647
2014
Q2
$29K Sell
2,300
-1,600
-41% -$13K ﹤0.01% 7633
2014
Q1
$22K Hold
3,900
﹤0.01% 7990
2013
Q4
$18K Buy
3,900
+3,300
+550% +$15K ﹤0.01% 8314
2013
Q3
$4K Buy
+600
New +$14.1K ﹤0.01% 9674

Other funds holding RNA

UBS's RNA Position: Q3 2014 in Review

UBS increased its PROSENSA HLDGS N V ORD SHS (NLD) (RNA) stake by 319% in Q3 2014, buying an estimated $31.4K and bringing the position to 4,353 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #7210.

UBS first reported a position in RNA in Q3 2013 and has held it in 4 quarters since. 32 funds tracked by Wall St. Rank hold RNA as of Q3 2014.

  • UBS held 4,353 shares of PROSENSA HLDGS N V ORD SHS (NLD) worth $37K as of Q3 2014.
  • UBS bought 3,315 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q3 2014, an estimated $31.4K.
  • PROSENSA HLDGS N V ORD SHS (NLD) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7210 holding.
  • UBS first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and has held it in 4 quarters since.
  • 32 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.